STERIS Return on Tangible Equity 2010-2023 | STE
Current and historical return on tangible equity values for STERIS (STE) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| STERIS Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2023-12-31 | $0.57B | $-0.67B | -78.18% |
| 2023-09-30 | $0.55B | $-0.91B | -71.75% |
| 2023-06-30 | $0.12B | $-0.57B | -15.36% |
| 2023-03-31 | $0.11B | $-0.75B | -11.73% |
| 2022-12-31 | $-0.03B | $-0.84B | 2.74% |
| 2022-09-30 | $-0.01B | $-0.97B | 0.69% |
| 2022-06-30 | $0.38B | $-1.10B | -29.04% |
| 2022-03-31 | $0.24B | $-1.19B | -16.69% |
| 2021-12-31 | $0.28B | $-1.37B | -23.78% |
| 2021-09-30 | $0.25B | $-1.54B | -29.27% |
| 2021-06-30 | $0.29B | $-1.75B | -96.87% |
| 2021-03-31 | $0.40B | $-0.03B | 140.26% |
| 2020-12-31 | $0.43B | $-0.09B | 104.26% |
| 2020-09-30 | $0.42B | $0.69B | 78.70% |
| 2020-06-30 | $0.41B | $0.57B | 91.63% |
| 2020-03-31 | $0.41B | $0.50B | 106.53% |
| 2019-12-31 | $0.39B | $0.40B | 121.58% |
| 2019-09-30 | $0.34B | $0.34B | 126.55% |
| 2019-06-30 | $0.32B | $0.30B | 152.15% |
| 2019-03-31 | $0.30B | $0.26B | 199.34% |
| 2018-12-31 | $0.27B | $0.17B | 264.37% |
| 2018-09-30 | $0.32B | $0.12B | 495.69% |
| 2018-06-30 | $0.30B | $0.07B | 1361.80% |
| 2018-03-31 | $0.29B | $0.06B | -1337.93% |
| 2017-12-31 | $0.24B | $0.02B | -335.17% |
| 2017-09-30 | $0.14B | $-0.05B | -119.92% |
| 2017-06-30 | $0.12B | $-0.11B | -79.47% |
| 2017-03-31 | $0.11B | $-0.15B | -62.29% |
| 2016-12-31 | $0.14B | $-0.17B | -70.94% |
| 2016-09-30 | $0.17B | $-0.17B | -70.49% |
| 2016-06-30 | $0.14B | $-0.21B | -71.71% |
| 2016-03-31 | $0.11B | $-0.24B | -121.98% |
| 2015-12-31 | $0.09B | $-0.32B | 417.78% |
| 2015-09-30 | $0.11B | $0.02B | 71.79% |
| 2015-06-30 | $0.13B | $0.18B | 66.50% |
| 2015-03-31 | $0.14B | $0.21B | 67.25% |
| 2014-12-31 | $0.13B | $0.22B | 60.18% |
| 2014-09-30 | $0.12B | $0.20B | 50.72% |
| 2014-06-30 | $0.12B | $0.18B | 45.94% |
| 2014-03-31 | $0.13B | $0.29B | 44.56% |
| 2013-12-31 | $0.13B | $0.31B | 47.31% |
| 2013-09-30 | $0.15B | $0.29B | 59.39% |
| 2013-06-30 | $0.16B | $0.27B | 63.01% |
| 2013-03-31 | $0.16B | $0.24B | 50.80% |
| 2012-12-31 | $0.16B | $0.21B | 43.37% |
| 2012-09-30 | $0.15B | $0.30B | 34.20% |
| 2012-06-30 | $0.14B | $0.50B | 29.42% |
| 2012-03-31 | $0.14B | $0.49B | 29.69% |
| 2011-12-31 | $0.13B | $0.45B | 28.84% |
| 2011-09-30 | $0.12B | $0.44B | 26.42% |
| 2011-06-30 | $0.13B | $0.47B | 28.05% |
| 2011-03-31 | $0.05B | $0.47B | 12.11% |
| 2010-12-31 | $0.04B | $0.43B | 10.14% |
| 2010-09-30 | $0.06B | $0.42B | 14.72% |
| 2010-06-30 | $0.06B | $0.39B | 13.25% |
| 2010-03-31 | $0.13B | $0.45B | 28.52% |
| 2009-12-31 | $0.13B | $0.42B | 28.65% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $23.267B | $5.139B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.656B | 27.71 |
| Intuitive Surgical (ISRG) | United States | $141.664B | 85.34 |
| Edwards Lifesciences (EW) | United States | $54.330B | 35.36 |
| DexCom (DXCM) | United States | $51.584B | 78.14 |
| IDEXX Laboratories (IDXX) | United States | $45.302B | 53.10 |
| Alcon (ALC) | Switzerland | $44.364B | 31.79 |
| IQVIA Holdings (IQV) | United States | $42.578B | 24.70 |
| Waters (WAT) | United States | $21.461B | 31.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.656B | 0.00 |
| Hologic (HOLX) | United States | $17.471B | 19.55 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.151B | 15.35 |
| ShockWave Medical (SWAV) | United States | $12.422B | 77.31 |
| Sysmex ADR (SSMXY) | Japan | $11.022B | 34.56 |
| Teleflex (TFX) | United States | $10.353B | 16.11 |
| Globus Medical (GMED) | United States | $8.736B | 25.61 |
| Penumbra (PEN) | United States | $7.935B | 90.18 |
| Masimo (MASI) | United States | $6.166B | 35.52 |
| Glaukos (GKOS) | United States | $5.610B | 0.00 |
| TransMedics (TMDX) | United States | $4.484B | 425.44 |
| Integer Holdings (ITGR) | United States | $3.944B | 23.83 |
| PROCEPT BioRobotics (PRCT) | United States | $3.558B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.422B | 20.32 |
| Tandem Diabetes Care (TNDM) | United States | $3.060B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.923B | 20.05 |
| Inari Medical (NARI) | United States | $2.732B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.428B | 20.53 |
| RxSight (RXST) | United States | $2.378B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.086B | 9.10 |
| Veracyte (VCYT) | United States | $1.800B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.604B | 0.00 |
| Artivion (AORT) | United States | $0.990B | 94.92 |
| OPKO Health (OPK) | United States | $0.941B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.919B | 17.88 |
| Silk Road Medical (SILK) | United States | $0.854B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.748B | 0.00 |
| Paragon 28 (FNA) | United States | $0.672B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.640B | 21.72 |
| SiBone (SIBN) | United States | $0.623B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.584B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
| IRadimed (IRMD) | United States | $0.534B | 29.89 |
| Pulse Biosciences (PLSE) | United States | $0.401B | 0.00 |
| Nevro (NVRO) | United States | $0.388B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.325B | 11.13 |
| Sight Sciences (SGHT) | United States | $0.276B | 0.00 |
| AxoGen (AXGN) | United States | $0.260B | 0.00 |
| NeuroPace (NPCE) | United States | $0.260B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.255B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.250B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.202B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.200B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.185B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.175B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.168B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.167B | 8.49 |
| Yubo Biotech (YBGJ) | China | $0.109B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.107B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.101B | 21.17 |
| Neuronetics (STIM) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.060B | 0.00 |
| Envoy Medical (COCH) | United States | $0.059B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| DarioHealth (DRIO) | United States | $0.055B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.051B | 0.00 |
| LENSAR (LNSR) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.034B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |